Press releases
* (R) = Regulatory press releases
Sep 10, 2021
(R) Cantargia completes patient recruitment to the phase IIa pancreatic cancer extension cohort in the CANFOUR study
Aug 30, 2021
(R) Cantargia reports preclinical data highlighting advantages of nadunolimab mechanism of action
Aug 19, 2021
(R) Cantargia expands CIRIFOUR trial after successful completion of recruitment in the pembrolizumab combination arm
Aug 19, 2021